Cite

HARVARD Citation

    de Bono, J. et al. (2019). Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial. Lancet oncology. 20 (3), pp. 383-393. [Online]. 
  
Back to record